Stocks
Immunome (IMNM) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -4.12 | 0.55 | 4.87 | -2.71 | -5.86 | -6.61 | ||
| Changes by years, y/y, % | +19% | -113% | +783% | -156% | +116% | +11.2% | |||
Immunome. EV/EBITDA
Immunome. EV/EBITDA, changes, %
Immunome (IMNM) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -1.27 | -2.95 | -3.84 | -5.77 | -8.55 | -6.61 | |
| Changes by years, y/y, % | -118% | -176% | -34% | +93% | +575% | |||
| Changes by quarters, q/q, % | -58% | +133% | +30% | +50% | +48% | |||
